-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Allovir, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
- Allovir, Inc. Current Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Allovir, Inc. Current Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -$265 K, a 126% decline year-over-year.
- Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2023 was -$126 K, a 52.5% increase from 2022.
- Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2022 was -$265 K, a 126% decline from 2021.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)